全球光声断层扫描市场规模、份额和趋势分析报告 – 行业概况和 2031 年预测

光声层析成像市场分析

光声断层扫描 (PAT) 市场正在经历大幅增长，因为它能够提供高分辨率、非侵入性成像，尤其是在检测癌症和心血管疾病等疾病方面。这项结合光学和超声技术的技术在医疗保健和研究领域都获得了广泛关注。由于临床前研究的增加和政府对创新技术的支持，北美和欧洲等主要地区的市场正在显著扩张。西门子医疗和 iThera Medical 等公司推出的混合成像系统和便携式设备等最新进展正在增强 PAT 的功能。随着研发投资的增加和早期疾病检测的日益普及，市场将继续增长。

光声层析成像市场规模

2023 年全球光声断层扫描市场规模价值 932.5 亿美元，预计到 2031 年将达到 3446.4 亿美元，2024 年至 2031 年预测期内的复合年增长率为 17.75%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

光声层析成像市场趋势

“便携式 PAT 设备发展日新月异”

The photoacoustic tomography (PAT) market is experiencing notable growth, driven by advancements in hybrid imaging systems, which combine photoacoustic and ultrasound technologies for improved diagnostic accuracy. A key trend shaping the market is the development of portable PAT devices, allowing for more flexible and point-of-care applications. For instance, iThera Medical recently introduced a portable photoacoustic imaging system that enhances the detection of cancerous tissues, providing real-time, high-resolution imaging. This trend towards mobility and enhanced diagnostic capabilities is increasing the adoption of PAT in clinical settings, particularly in oncology and cardiovascular disease monitoring. Furthermore, the growing investment in research and development, especially in Europe and North America, is propelling the market forward, with academic institutions and hospitals increasingly leveraging photoacoustic tomography for non-invasive imaging. These advancements are expanding the application range of PAT and  positioning it as a crucial tool in early disease detection and personalized medicine.

Report Scope and Photoacoustic Tomography Market Segmentation

Photoacoustic Tomography Market Definition

Photoacoustic tomography (PAT) is a non-invasive imaging technique that combines laser-induced ultrasound with optical imaging to provide detailed images of tissues and organs. By using laser pulses to excite tissues, PAT detects the ultrasonic waves generated as a result of tissue absorption, offering high-resolution, real-time images of biological structures at deeper levels than conventional optical imaging.

Photoacoustic Tomography Market Dynamics

Drivers

• Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant driver of the photoacoustic tomography (PAT) market, as conditions such as cancer and cardiovascular disorders continue to escalate globally. For instance, the World Health Organization (WHO) projects that cancer cases will rise significantly over the next decade, with an estimated nearly 30 million new cases expected annually by 2040. In addition, cardiovascular diseases remain the leading cause of death worldwide, claiming approximately 17.9 million lives each year, according to WHO statistics. This alarming trend underscores the urgent need for advanced diagnostic tools that enable early detection and accurate monitoring of these diseases. Photoacoustic tomography offers a unique advantage by combining the high spatial resolution of optical imaging with the deep tissue penetration of ultrasound, allowing for precise visualization of tumor vasculature and cardiac structures without invasive procedures. As healthcare providers seek to improve patient outcomes through timely interventions, the increasing demand for non-invasive and effective diagnostic solutions such as PAT will continue to drive market growth.

• Growing Research and Development (R&D) Investments

Growing research and development (R&D) investments significantly propel the photoacoustic tomography (PAT) market, as both academic institutions and private organizations intensify their efforts to explore its diverse applications in healthcare. For instance, the National Institutes of Health (NIH) in the U.S. has allocated substantial funding for research focused on advanced imaging techniques, including photoacoustic methods. This financial backing fosters innovation and enhances collaboration between universities and industry leaders, resulting in novel PAT applications in oncology, cardiology, and neurology. Moreover, private organizations such as Siemens and Canon are actively investing in developing state-of-the-art PAT devices to expand their imaging portfolios, further stimulating advancements in the field. As R&D initiatives continue to flourish, they are expected to broaden the clinical capabilities of photoacoustic tomography, driving its adoption across multiple medical disciplines and thereby fueling market growth.

Opportunities

• Growing Advancements in Imaging Technology

Advancements in imaging technology, particularly in photoacoustic tomography (PAT) systems, are significantly transforming the landscape of diagnostic imaging. Innovations such as enhanced resolution and multi-modal imaging capabilities are enabling clinicians to obtain more detailed and accurate images of tissues, leading to better diagnostic outcomes. For instance, the integration of PAT with ultrasound imaging allows for the simultaneous assessment of anatomical structures and functional information, which is crucial in detecting and characterizing tumors. Such technological improvements are creating opportunities for PAT to be applied in various medical fields, including oncology, cardiology, and neurology, ultimately enhancing patient care. The growing demand for more precise and non-invasive diagnostic tools positions the photoacoustic tomography market for significant expansion.

• Expanding Applications of Photoacoustic Tomography (PAT) in Cancer Detection

The expanding applications of photoacoustic tomography (PAT) in cancer detection are paving the way for early diagnosis and improved patient outcomes, particularly in breast cancer and melanoma. PAT leverages the unique optical properties of tissue, allowing for the visualization of vascular structures and the biochemical composition of tumors. For instance, studies have shown that PAT can detect breast tumors at much earlier stages than conventional imaging techniques such as mammography, by providing high-resolution images that reveal metabolic changes in the tissue. This capability enhances the accuracy of tumor characterization and aids in treatment planning and monitoring. As the demand for early and precise cancer detection continues to rise, the market for PAT is poised for significant growth, offering healthcare providers a powerful tool for improving diagnostic accuracy and patient management.

Restraints/Challenges

• High Costs of Photoacoustic Tomography Equipment

High initial costs associated with photoacoustic tomography equipment and technology pose a significant barrier to widespread adoption, particularly for smaller medical facilities and research institutions that may lack the financial resources to invest in such advanced imaging systems. For instance, a photoacoustic imaging system can cost upwards of several hundred thousand dollars, which may be prohibitive for clinics with limited budgets. This financial hurdle restricts access to the technology, preventing many healthcare providers from incorporating photoacoustic tomography into their diagnostic and research capabilities. Consequently, the high costs of entry into this market challenge the overall growth and accessibility of photoacoustic imaging solutions.

• Significant Competition from Established Imaging Modalities

Photoacoustic tomography encounters significant competition from established imaging modalities such as MRI and CT scans, which are widely recognized and trusted by healthcare providers and patients alike as. These traditional imaging techniques have a long history of clinical use, robust infrastructure, and extensive research backing their efficacy and reliability. For instance, MRI is often preferred for soft tissue imaging due to its high resolution and ability to differentiate between various tissue types, while CT scans are commonly utilized for their speed and effectiveness in detecting structural abnormalities. As a result, healthcare providers may prioritize these conventional modalities over newer technologies such as photoacoustic tomography, which can impede its acceptance and integration into clinical practice. This competition from established imaging methods represents a substantial challenge for the growth of the photoacoustic tomography market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Photoacoustic Tomography Market Scope

The market is segmented on the basis of type, application, geometry, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Photoacoustic Tomography
• Photoacoustic Microscopy
• Intravascular Photoacoustic Imaging

Application

• Cardiovascular Disease (CVD)
• Lymphatic
• Diagnosis and Monitoring
• Clinical Research
• Others

Geometry

• Planar
• Cylindrical
• Spherical

End User

• Hospitals
• Diagnostics
• Imaging Centers
• Academic
• Research Institutes

Photoacoustic Tomography Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, application, geometry, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America holds a dominant position in the photoacoustic tomography market, primarily driven by the growing number of pre-clinical studies conducted in academic and research institutes across the region. In addition, the presence of key industry players enhances the development and adoption of advanced imaging technologies. This strong research foundation and market leadership are expected to further propel the growth of the photoacoustic tomography market in North America during the forecast period.

预计欧洲的光声断层扫描市场将大幅增长，这得益于该地区越来越多地采用先进的成像技术。此外，政府旨在支持创新医疗设备开发的举措，以及对研发活动的大量投资，预计将进一步推动市场发展。这些因素可能会推动欧洲光声断层扫描市场在未来几年的扩张。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。  

光声层析成像市场份额

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

光声断层扫描市场领导者有：

• PerkinElmer (美国)
• 布鲁克 (美国)
• 富士胶片株式会社（日本）
• Mediso 有限公司 (匈牙利)
• MILabs BV（荷兰）
• 通用电气公司（美国）
• Koninklijke Philips NV（荷兰）
• MR Solutions（英国）
• Aspect Imaging Ltd.（以色列）
• 佳能印度私人有限公司 (印度)
• OPOTEK LLC（美国）
• 日立高科技公司（日本）
• LI-COR, Inc.（美国）
• Miltenyi Biotec（德国）
• ENDRA Life Sciences Inc.（美国）
• 西门子医疗股份公司（德国）
• PreXion Inc.（美国）
• iThera Medical GmbH（德国）
• 基贝罗（德国）

光声层析成像市场的最新发展

• 2022 年 11 月，Seno Medical 宣布推出其 Imagio 乳腺成像系统，引入了一种新的乳腺成像方式。该系统将于 11 月 27 日至 12 月 1 日在芝加哥举行的 RSNA 年度科学大会和年会上亮相
• 2022 年 5 月，富士胶片株式会社（日本）（FUJIFILM VisualSonics, Inc.）推出了 Vevo F2，这是一款能够在 71 MHz 至 1 MHz 的超宽频率范围内运行的超声和光声成像系统。这款创新系统标志着超高频超声和光声成像技术的重大进步
• 2021 年 10 月，iThera Medical 推出了其新的 inVision TRIO 临床前光声成像系统。这款升级产品将三种成像模式集成到一个系统中。inVision TRIO 是全球首个采用透射超声计算机断层扫描 (TUCT) 的成像系统，从而扩大了 iThera Medical 光声成像系统可以解决的生物应用范围
• 2021 年 1 月，EKSPLA 宣布与总部位于法国的领先激光器和光子产品分销商 Opton Laser International (OLI) 建立合作伙伴关系。此次合作将增强 EKSPLA 所有产品的销售和分销，光纤激光器除外
• 2020 年 4 月，Ekspla 推出了专为光声成像应用而设计的高能激光源的升级版。PhotoSonus+ 光声成像激光源具有高能 Q 开关激光器、参数振荡器、电源和冷却单元，所有这些都集成在坚固的推车式外壳中，以增强移动性、易用性并降低维护成本

SKU-47822